Two year Cottbus reinfarction study with 30 mg aspirin per day
- 30 November 1991
- journal article
- clinical trial
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 44 (3) , 159-169
- https://doi.org/10.1016/0952-3278(91)90051-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The effects of different doses of some acetylsalicylic acid formulations on platelet function and bleeding times in healthy subjectsScandinavian Journal of Haematology, 2009
- In vitro bleeding test - a simple method for the detection of aspirin effects on platelet functionThrombosis Research, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Antiaggregative Aspirin Dosage at the Affected Vessel WallAngiology, 1986
- Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in manProstaglandins, 1986
- Cumulative antiplatelet effect of low‐dose enteric coated aspirinBritish Journal of Haematology, 1985
- Low‐dose acetylsalicylic acid (100 mg/day) after aortocoronary bypass surgery: a placebo‐controlled trial.British Journal of Clinical Pharmacology, 1984
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in manEuropean Journal of Clinical Pharmacology, 1983